International Competition: Key Risks, Deadlines, and Next Steps

The critical insight is that your company faces antitrust scrutiny from multiple sovereigns simultaneously, even if you operate primarily in the United States. The Federal Trade Commission, Department of Justice, and state attorneys general all have enforcement authority. Add foreign regulators, the European Commission, UK Competition and Markets Authority, China's State Administration for Market Regulation, and the compliance burden becomes exponential. These agencies do not coordinate enforcement; they often reach conflicting conclusions on the same conduct. A pricing strategy or distribution arrangement that the FTC might tolerate could trigger criminal prosecution in Germany or result in a massive fine from Brussels.

From a practitioner's perspective, the real challenge is that each jurisdiction applies different substantive standards and burdens of proof. EU law, for example, treats many vertical restraints and information exchanges as per se violations, while U.S. .ourts apply a rule of reason analysis that permits procompetitive justifications. This means conduct that passes muster under Sherman Act precedent may violate Article 101 of the Treaty on the Functioning of the European Union. Companies that assume U.S. .ompliance automatically satisfies foreign regulators often discover too late that they face parallel investigations, separate fines, and conflicting remedies.

If your company is acquiring a competitor or significant market player abroad, merger review is not optional. The Hart-Scott-Rodino Act requires U.S. .iling for transactions above certain thresholds; EU merger review applies to deals with worldwide revenues exceeding specified levels and significant EU-wide sales; China, the UK, and other jurisdictions maintain separate filing requirements. The deadlines are not uniform, and missing a single filing can result in unwinding the deal, substantial penalties, or both.

Here is the practical trap: companies often structure transactions to close in one jurisdiction while waiting for clearance in another. This is dangerous. Regulators view the global transaction as a single event and may impose remedies, asset sales, licensing arrangements, or behavioral commitments, that were not contemplated in the deal structure. In one recent matter, a U.S. .cquirer and a European target completed their closing before EU approval, triggering an investigation and a forced divestiture that destroyed deal economics. The transaction had been reviewed by both parties' counsel and deemed compliant under U.S. .tandards; the EU simply applied a different competitive analysis.

Criminal prosecution for price-fixing, bid-rigging, and market allocation is a live threat in the United States, EU, UK, and most developed economies. The U.S. Department of Justice has secured prison sentences for individuals involved in international cartels; the EU imposes fines of up to 10 percent of worldwide turnover and routinely prosecutes individuals. The difference between civil antitrust liability and criminal exposure often turns on intent and the sophistication of concealment, but international cartels, particularly those involving meetings, coded communications, or deliberate secrecy, cross into criminal territory quickly.

Conduct that may seem benign in one cultural or business context can constitute cartel behavior under foreign law. Information exchanges among competitors at trade shows, joint ventures with price-setting provisions, or even parallel pricing in tight oligopolies have triggered investigations. The U.S. Sentencing Guidelines and EU enforcement practice both emphasize the duration and scope of the conspiracy; a cartel spanning multiple countries and years can generate fines in the hundreds of millions and individual prison sentences.

The takeaway is that antitrust due diligence must precede any significant cross-border transaction or joint venture. Before signing, engage counsel to map regulatory requirements across all relevant jurisdictions, identify filing deadlines, and assess competitive risk under each regime. Do not assume that U.S. .ounsel's clearance satisfies foreign regulators. Many companies benefit from engaging local counsel in key markets, EU counsel, UK counsel, China counsel, to stress-test the transaction structure and identify mitigation strategies.

In New York practice, the Southern District of New York has handled several high-profile international cartel prosecutions and has become increasingly active in foreign investment screening under CFIUS authority. If your company faces a federal antitrust investigation or a parallel foreign investigation, early coordination with experienced counsel is critical. The SDNY and the Antitrust Division of the DOJ move quickly; delays in securing representation often result in lost opportunities for negotiation or early resolution.

For companies in the midst of international acquisition discussions, the compliance framework should include a dedicated antitrust and competition review by counsel familiar with both U.S. and foreign enforcement trends. This is not a box-checking exercise; it is a strategic assessment that can reshape deal structure, pricing, and governance.

As you evaluate international expansion or acquisition opportunities, consider whether your current compliance infrastructure, training programs, deal review protocols, and information barriers, is adequate for the jurisdictions you are entering. Many companies discover gaps only after regulatory scrutiny begins. A candid internal audit now, before deal pressure mounts, often prevents far more costly problems later.